Skip to main content
. 2015 Nov 15;33(4):275–282. doi: 10.1097/EJA.0000000000000405

Table 1.

Patients’ characteristics and operative data

Dex group (n = 25) Control group (n = 25)
Age (years) 68.4 ± 6.4 69.4 ± 8.7
Sex (M/F) 12/13 11/14
Height (cm) 162.9 ± 6.9 162.3 ± 8.4
Weight (kg) 60.8 ± 8.9 61.3 ± 8.9
BMI (kg m−2) 22.3 ± 2.7 22.7 ± 2.1
ASA physical status, 2/3 11/14 12/3
Hypertension 10 11
Cardiovascular medication
 RAAS inhibitor 8 8
 Calcium channel blocker 1 2
 β-adrenergic antagonists 0 1
 Furosemide 2 2
Smoking
 Ex-smoker/current smoker 11/12 14/10
 Smoking index, pack-years 36.7 ± 27.1 35.8 ± 28.9
 Non-smoker 2 1
Medication
 Inhaled corticosteroid 42.7% 39.5%
 Oral corticosteroid 18.6% 14.3%
 Inhaled bronchodilator 21.3% 17.9%
 Oral bronchodilator 33.6% 34.2%
 Muscarinic antagonists 3.7% 3.2%
Preoperative SpO2, % 93.8 ± 1.2 94.1 ± 1.3
Preoperative spirometry
 FEV1, % predicted 60.8 ± 5.2 61.4 ± 4.1
 FVC, % predicted 82.7 ± 8.6 83.1 ± 7.2
 FEV1/FVC, % 55.9 ± 3.2 56.1 ± 5.7
 FEF25–75%, l s−1 26.4 ± 18.9 27.1 ± 19.3
 FEF50%, l s−1 18.9 ± 11.3 19.3 ± 12.7
 DLco, % predicted 93.6 ± 8.2 92.3 ± 7.6
Intraoperative data
 Anaesthesia time (min) 193.6 ± 24.6 189.7 ± 44.1
 Operation time (min) 163.8 ± 39.4 158.1 ± 33.2
 OLV time (min) 125.6 ± 37.1 124.7 ± 41.2
 Fluid intake (ml) 791.4 ± 92.3 813.2 ± 79.5
 Urine output (ml) 274.5 ± 132.6 354.6 ± 132.7
 Estimated blood loss (ml) 122.4 ± 55.6 125.6 ± 84.7
Number receiving ephedrine 9* 1
Right/left lobectomy 17/8 16/9
 Right upper lobe 8 5
 Right middle lobe 2 5
 Right lower lobe 7 6
 Left upper lobe 4 6
 Left lower lobe 4 3

Values are mean ± SD, number or percentage of patients. ASA, American Society of Anesthesiologists; DLco, diffusion capacity of lung for carbon monoxide; FEF25–75%, forced expiratory volume between 25 and 75% of the FVC; FEF50%, forced expiratory volume 50% of the FVC; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; OLV, one-lung ventilation; RAAS, renin–angiotensin–aldosterone system; SpO2, oxygen saturation (pulse oximetry).

*P < 0.05 vs. control group.